Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - GROSS PROFIT
Gross Profit YMAB - Y-mAbs Therapeutics, Inc.
72.4 M
LAST VALUE
12.04%
2 YEAR CAGR
237.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR